全文获取类型
收费全文 | 217548篇 |
免费 | 3595篇 |
国内免费 | 259篇 |
专业分类
耳鼻咽喉 | 1493篇 |
儿科学 | 7856篇 |
妇产科学 | 4155篇 |
基础医学 | 22077篇 |
口腔科学 | 2457篇 |
临床医学 | 16625篇 |
内科学 | 40012篇 |
皮肤病学 | 1528篇 |
神经病学 | 21004篇 |
特种医学 | 10228篇 |
外科学 | 34283篇 |
综合类 | 2477篇 |
一般理论 | 19篇 |
预防医学 | 21180篇 |
眼科学 | 3460篇 |
药学 | 12074篇 |
1篇 | |
中国医学 | 708篇 |
肿瘤学 | 19765篇 |
出版年
2024年 | 70篇 |
2023年 | 522篇 |
2022年 | 999篇 |
2021年 | 1804篇 |
2020年 | 1065篇 |
2019年 | 1497篇 |
2018年 | 23333篇 |
2017年 | 18326篇 |
2016年 | 20583篇 |
2015年 | 2405篇 |
2014年 | 2881篇 |
2013年 | 3353篇 |
2012年 | 10712篇 |
2011年 | 24616篇 |
2010年 | 20576篇 |
2009年 | 13186篇 |
2008年 | 22341篇 |
2007年 | 24418篇 |
2006年 | 3155篇 |
2005年 | 4741篇 |
2004年 | 5509篇 |
2003年 | 6229篇 |
2002年 | 4167篇 |
2001年 | 482篇 |
2000年 | 549篇 |
1999年 | 384篇 |
1998年 | 493篇 |
1997年 | 417篇 |
1996年 | 288篇 |
1995年 | 279篇 |
1994年 | 248篇 |
1993年 | 177篇 |
1992年 | 121篇 |
1991年 | 157篇 |
1990年 | 182篇 |
1989年 | 114篇 |
1988年 | 89篇 |
1987年 | 71篇 |
1986年 | 56篇 |
1985年 | 59篇 |
1984年 | 56篇 |
1983年 | 39篇 |
1982年 | 63篇 |
1980年 | 60篇 |
1969年 | 24篇 |
1938年 | 60篇 |
1937年 | 25篇 |
1934年 | 30篇 |
1932年 | 56篇 |
1930年 | 46篇 |
排序方式: 共有10000条查询结果,搜索用时 9 毫秒
991.
992.
Mitch Dowsett 《Breast cancer research and treatment》2004,87(1):11-18
cDNA arrays and proteomic analyses have allowed the rapid identification of specific genes and proteins implicated in multiple
tumor types. These molecules must then be validated as clinically relevant prognostic and predictive markers, and this translational
research is best conducted in the context of clinical trials. Outcomes data and clinical specimens collected in the ‘Arimidex’,
Tamoxifen, Alone or in Combination (ATAC) study, for example, can now be used to compare the expression of biomarkers with
clinical outcomes. In this study, adjuvant tamoxifen and anastrozole (‘Arimidex’) were compared alone and in combination in
more than 9000 women with breast cancer. Anastrozole was found to be superior to tamoxifen in terms of disease-free survival,
time to recurrence, and reduction in the incidence of contralateral tumors. Importantly, tissue specimens from surgical excision,
local relapse, and contralateral breast cancer were collected and paraffin-embedded for storage. In the TA01 (TransATAC) program,
these specimens will be studied (after obtaining patient consent) using tissue microarrays; tissue biopsy cores 0.6 mm in
diameter will be removed from donor blocks and placed on recipient blocks, which will be sectioned to allow the simultaneous
analysis of the same samples for multiple biomarkers. These analyses can help determine differential benefits of treatment
with anastrozole or tamoxifen, depending on the expression of particular biomarkers in tumor cells. This research also should
clarify de novo and acquired resistance mechanisms, and the validation of relevant molecular pathways could guide the development of new
drugs. Ultimately, the TA01 program has the potential to favorably impact treatment choices for breast cancer.
This revised version was published online in August 2006 with corrections to the Cover Date. 相似文献
993.
In vivo assessment of antiangiogenic activity of SU6668 in an experimental colon carcinoma model. 总被引:10,自引:0,他引:10
Pasquina Marzola Anna Degrassi Laura Calderan Paolo Farace Caterina Crescimanno Elena Nicolato Anna Giusti Enrico Pesenti Andrea Terron Andrea Sbarbati Tinya Abrams Lesley Murray Francesco Osculati 《Clinical cancer research》2004,10(2):739-750
PURPOSE: The purpose of this research was to assess in vivo by dynamic contrast enhanced magnetic resonance imaging (DCE-MRI) the antiangiogenic effect of SU6668, an oral, small molecule inhibitor of the angiogenic receptor tyrosine kinases vascular endothelial growth factor receptor 2 (Flk-1/KDR), platelet-derived growth factor receptor, and fibroblast growth factor receptor 1. EXPERIMENTAL DESIGN: A s.c. tumor model of HT29 human colon carcinoma in athymic mice was used. DCE-MRI with a macromolecular contrast agent was used to measure transendothelial permeability and fractional plasma volume, accepted surrogate markers of tumor angiogenesis. CD31 immunohistochemical staining was used for assessing microvessels density and vessels area. Experiments were performed after 24 h, and 3, 7, and 14 days of treatment. RESULTS: DCE-MRI clearly detected the early effect (after 24 h of treatment) of SU6668 on tumor vasculature as a 51% and 26% decrease in the average vessel permeability measured in the tumor rim and core (respectively). A substantial decrease was also observed in average fractional plasma volume in the rim (59%) and core (35%) of the tumor. Histological results confirmed magnetic resonance imaging findings. After 3, 7, and 14 days of treatment, postcontrast magnetic resonant images presented a thin strip of strongly enhanced tissue at the tumor periphery; histology examination showed that this hyperenhanced ring corresponded to strongly vascularized tissue adjacent but external to the tumor. Histology also revealed a strong decrease in the thickness of peripheral viable tissue, with a greatly reduced vessel count. SU6668 greatly inhibited tumor growth, with 60% inhibition at 14 days of treatment. CONCLUSIONS: DCE-MRI detected in vivo the antiangiogenic efficacy of SU6668. 相似文献
994.
Elevated expression of A3 adenosine receptors in human colorectal cancer is reflected in peripheral blood cells. 总被引:1,自引:0,他引:1
995.
Background Duodenogastric reflux is known to cause an increased frequency of cancer in the glandular portion of the stomach in rats. Furthermore, it is debated whether inhibition of gastric acid secretion may promote gastric carcinogenesis. In the present study we examined the combined effect of gastroduodenal reflux and acid inhibition with respect to the development of gastric carcinoma in the rat.Methods Following the construction of a gastrojejunostomy in male Wistar rats, half of them were given the proton pump inhibitor lanzoprazole for 1 year. The rats were then killed and the pH in the stomach and gastrin in blood were measured. The stomach was examined macroscopically as well as histologically.Results Gastrin levels at autopsy were significantly increased in treated rats compared to the control group, confirming an effect of lanzoprazole on gastric acid secretion. Body weight was significantly reduced in the treated rats. Thirty of 79 rats developed gastric cancer, and they were all adenocarcinomas of the Lauren intestinal type. Gastric cancers occurred significantly more often in lanzoprazole-treated rats (50%) compared with controls (27%).Conclusion Lanzoprazole given orally enhances the carcinogenic effect of duodenogastric reflux in rats. 相似文献
996.
Efficiency of adjuvant immunochemotherapy following curative resection in patients with locally advanced gastric cancer 总被引:3,自引:0,他引:3
Tadeusz Popiela Jan Kulig Antoni Czupryna Antoni M. Szczepanik Marek Zembala 《Gastric cancer》2004,7(4):240-245
Background Despite curative resection, 50%–90% of gastric cancer patients die of disease relapse. Although some clinical trials have indicated that chemotherapy and immunochemotherapy may be effective modalities, more recent studies have not been able to define the standard treatment for advanced gastric cancer. The present study evaluated the effect of adjuvant immunochemotherapy with the use of BCG (bacille Calmette-Guérin) and FAM (5-fluorouracil, adriamycin, mitomycin C) chemotherapy on the survival of patients with locally advanced resectable gastric cancer.Methods A total of 156 patients with stage III or IV gastric cancer who had undergone curative resection were randomly assigned to three treatment groups: BCG + FAM (immunochemotherapy), FAM (chemotherapy), and control (surgery only). Treatment was continued for 2 years or until death. Further postsurgical follow up was carried on for up to 10 years.Results Overall 10-year survival was 47.1% for the immunochemotherapy group (P < 0.037 vs FAM and P < 0.0006 vs control), 30% for the chemotherapy group (vs control, NS), and 15.2% for the control group. In patients with pT2/T3 primary tumors, 10-year survival was 55.3% for BCG + FAM vs 28.2% for FAM (P < 0.01) and 14.6% for the control group (P < 0.00018). BCG + FAM signifi-cantly improved the survival of patients with intestinal-type but not diffuse-type cancer. Immunochemotherapy was well tolerated.Conclusion This study, based on a limited number of patients, indicates that adjuvant immunochemotherapy (BCG + FAM) may prolong the survival of gastric cancer patients after curative gastrectomy; in particular, in patients with pT2/T3 tumors and intestinal-type primary tumors. There was no survival benefit from FAM adjuvant chemotherapy. 相似文献
997.
998.
According to differentiation of symptoms and signs, prostatosis was divided into pattern of dampness and heat in the lower
energizer, pattern of qi stagnation and blood stasis, pattern of deficiency and cold in the lower abdomen, and pattern of
qi deficiency and kidney deficiency. Prostatosis were treated mainly by acupuncture, plus moxibustion and Chinese medicine,
and the effect was good.
Author: Zhao Chang-quan (1949-), male, junior consultant doctor
Translator: Huang Guo-qi 相似文献
999.
Chen Feng 《针灸推拿医学(英文版)》2003,1(1):42-43
Yaoyangguan (GV 3), Shiqizhui (Ex-B 8) and Yanglingquan (GB 34) were selected as main points and a three-part needle insertion
technique was used to treat 32 cases of lumbar intervertebral disc protrusion. The curative rate was 96.9%. Deep puncture
is the key to the treatment.
Author: Chen Feng(1962-), male, junior consultant doctor
Translator: Wang Si-you 相似文献
1000.
Shen Guo-quan 《针灸推拿医学(英文版)》2003,1(5):59-60
In the performance of rubbing manipulation, because of the fingers comparatively light vertical pressure and large-range circular movement, the palm and fingers cannot adhere to the patient's skin, and the relative friction movement. 相似文献